Buphenine Hydrochloride

็›้…ธๅธƒ้…šๅฎ

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBuphenine Hydrochloride
Drug Alias Namebufenina็›้…ธ่‹„ไธ™้…š่ƒบbupheninumๅธƒ่Šฌๅฎ็›้…ธ็›Nylidrin +[7]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors agonists
TargetsBeta adrenergic receptors
Therapy Area/IndicationsPeripheral Vascular DiseasesCoronary Artery DiseaseCerebrovascular Disorders
Global Approved IndicationsPeripheral Vascular DiseasesCoronary Artery DiseaseCerebrovascular Disorders
Approved Indications in ChinaPeripheral Vascular DiseasesCoronary Artery DiseaseCerebrovascular Disorders
Original Approved Country/TerritoryUnited States
Original Approved Date1955/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesYunnan Baiyao Group Co Ltd
Inactive CompaniesN/A
Active IndicationsPeripheral Vascular DiseasesCoronary Artery DiseaseCerebrovascular Disorders
Inactive IndicationsN/A

Other Information

ATC CodeC04AA02G02CA02
Related LinksWikipediaKEGG